When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Sofosbuvir - Wikipedia

   en.wikipedia.org/wiki/Sofosbuvir

   On one hand, this agent offers up to a 95% response rate as part of an interferon-free treatment regimen for hepatitis C. Generally speaking, it is more effective and better tolerated than alternative treatments. Unfortunately, the current per pill cost—$1,000—results in an $84,000 treatment course, creating barriers to therapy for many.

3. We have a cure for hepatitis C. Why are hundreds of New ... - AOL

   www.aol.com/news/cure-hepatitis-c-why-hundreds...

   Direct-acting antivirals can cure one of the nation's deadliest bloodborne diseases. But Medicaid restrictions and other barriers stand in the way. We have a cure for hepatitis C.

4. Drugs approved a decade ago can cure hepatitis C, but most ...

   www.aol.com/drugs-approved-decade-ago-cure...

   For premium support please call: 800-290-4726 more ways to reach us

5. Obinutuzumab - Wikipedia

   en.wikipedia.org/wiki/Obinutuzumab

   Obinutuzumab has two black box warnings: hepatitis B reactivation and progressive multifocal leukoencephalopathy. [7] [5]In the clinical trial of obinutuzumab in combination with chlorambucil, participants experienced infusion reactions (69%; 21% grade 3/4), neutropenia (40%; 34% grade 3/4), thrombocytopenia (15%; 11% grade 3/4), anemia (12%), and pyrexia and cough (10% each).

6. Hepatitis - Wikipedia

   en.wikipedia.org/wiki/Hepatitis

   Chronic hepatitis C progresses towards cirrhosis, with estimates of cirrhosis prevalence of 16% at 20 years after infection. [126] While the major causes of mortality in hepatitis C is end stage liver disease, hepatocellular carcinoma is an important additional long term complication and cause of death in chronic hepatitis.

7. Gilead Sciences - Wikipedia

   en.wikipedia.org/wiki/Gilead_Sciences

   Gilead Sciences, Inc. (/ ˈ ɡ ɪ l i ə d /) is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.